Press release
Investigation announced for Investors in Valneva SE (NASDAQ: VALN) shares over potential Wrongdoing
An investigation on behalf of investors in Valneva SE (NASDAQ: VALN) shares over potential wrongdoing at Valneva SE was announced.
Investors who purchased shares of Valneva SE (NASDAQ: VALN) s have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether NASDAQ: VALN officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
France based Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs.
On or about May 6, 2021, Valneva SE (NASDAQ: VALN) sold approximately 3.5 million shares of stock in its initial public stock offering (the "IPO") at $26.41 a share, raising nearly $100 million in new capital.
On September 13, 2021, Valneva SE (NASDAQ: VALN) reported the UK Government has terminated an agreement for its Covid-19 vaccination over allegations of a breach of the agreement.
Shares of Valneva SE (NASDAQ: VALN) declined to as low as $24.83 per share on September 20, 2021.
Those who purchased shares of Valneva SE (NASDAQ: VALN) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Valneva SE (NASDAQ: VALN) shares over potential Wrongdoing here
News-ID: 2450047 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Valneva
Valneva and EuBiologics Drive Oral Cholera Vaccine Breakthroughs in Europe
Cholera Vaccines Market Europe: Developments and Global Contributions in 2025
The Cholera Vaccines Market Europe is evolving in 2025 with a strategic focus on innovation, global support, and production scalability. While Europe is not a region with endemic cholera outbreaks, it remains a critical player in the international effort to combat cholera through vaccine development, regulatory support, and funding initiatives.
Get the Free Sample Research Report Copy on Cholera Vaccines Market Europe:…
Vaccine Adjuvants Market Is Booming Worldwide | Pfizer, Valneva, Viropro
According to USD Analytics the Global Vaccine Adjuvants Market is estimated to increase at a Compounded Annual Growth Rate of 13.7% CAGR over the forecast period from 2024 to 2030
The latest study released on the Global Vaccine Adjuvants Market by USD Analytics Market evaluates market size, trend, and forecast to 2032. The Vaccine Adjuvants market study covers significant research data and proofs to be a handy resource document for managers,…
Cholera Vaccines Market Is Booming Worldwide with PaxVax, Valneva, Sanofi
The "Global Cholera Vaccines" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global Cholera Vaccines provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study…
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time.
Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing…
Investigation announced for Investors in Valneva SE (NASDAQ: VALN) shares
An investigation was announced over potential securities laws violations by Valneva SE in connection with certain financial statements.
Investors who purchased shares of Valneva SE (NASDAQ: VALN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Valneva SE (NASDAQ: VALN) concerning whether a series of statements…
Cholera Vaccines Market Coping With Emerging Technologies | Huge Growth By 2025 …
This report is an extensive analysis of current and potential trends in the Cholera Vaccines market. The report provides an in-depth quantitative analysis of the current and future market estimations which helps to recognize the prevailing market opportunities. Key market players within the market are profiled in this report and their strategies are analysed completely which help to understand the competitive outlook 2020-2024.
Global Cholera Vaccines Market Overview:
A recent report by…
